- Home
- MRUS vs SHC Comparison
MRUS vs SHC Comparison
Compare MRUS & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- SHC
- Stock Information
- Founded
- MRUS 2003
- SHC 2015
- Country
- MRUS Netherlands
- SHC United States
- Employees
- MRUS N/A
- SHC 3000
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- SHC Medical Specialities
- Sector
- MRUS Health Care
- SHC Health Care
- Exchange
- MRUS Nasdaq
- SHC Nasdaq
- Market Cap
- MRUS 5.1B
- SHC 4.6B
- IPO Year
- MRUS 2016
- SHC 2020
- Fundamental
- Price
- MRUS $94.38
- SHC $15.87
- Analyst Decision
- MRUS Buy
- SHC Strong Buy
- Analyst Count
- MRUS 18
- SHC 5
- Target Price
- MRUS $93.72
- SHC $17.20
- AVG Volume (30 Days)
- MRUS 4.2M
- SHC 1.7M
- Earning Date
- MRUS 10-30-2025
- SHC 11-04-2025
- Dividend Yield
- MRUS N/A
- SHC N/A
- EPS Growth
- MRUS N/A
- SHC N/A
- EPS
- MRUS N/A
- SHC 0.08
- Revenue
- MRUS $56,228,000.00
- SHC $1,124,535,000.00
- Revenue This Year
- MRUS $47.25
- SHC $6.23
- Revenue Next Year
- MRUS N/A
- SHC $5.99
- P/E Ratio
- MRUS N/A
- SHC $189.49
- Revenue Growth
- MRUS 59.77
- SHC 2.40
- 52 Week Low
- MRUS $33.19
- SHC $9.53
- 52 Week High
- MRUS $94.56
- SHC $16.64
- Technical
- Relative Strength Index (RSI)
- MRUS 86.13
- SHC 52.07
- Support Level
- MRUS $66.13
- SHC $15.70
- Resistance Level
- MRUS $94.45
- SHC $16.54
- Average True Range (ATR)
- MRUS 1.00
- SHC 0.47
- MACD
- MRUS 1.49
- SHC -0.05
- Stochastic Oscillator
- MRUS 99.38
- SHC 50.44
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About SHC Sotera Health Company
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.